Risk-Based Monitoring – What We’ve Learnt in a Year, a Large Pharma Perspective from Sanofi, New Webinar Hosted by Xtalks
Toronto, Canada (PRWEB) May 06, 2014 -- Sanofi started to investigate general issues around scientific misconduct back in 2008 with IDDI (CluePoints’ parent company) and then implemented CSM with CluePoints since 2012. This session will showcase the impact that Sanofi had on enhancing a technology-driven approach using Central Statistical Monitoring Techniques.
For more information on this webinar or to register, visit Risk-Based Monitoring – What we’ve learnt in a year, a Large Pharma Perspective from Sanofi.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com.
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx.
Contact:
Michelle Tran
Tel: +1 (416) 977-6555 ext 352
Email: mtran(at)xtalks(dot)com
Client Services, Xtalks, +1 (416) 977-6555 Ext: 227, [email protected]
Share this article